PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
ConditionChronic Hand Eczema
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCorEvitas
About this trial
The design is a prospective, observational registry for subjects with CHE under the care of dermatology or other qualified healthcare provider. Longitudinal data are collected from both subjects and their treating provider during routine clinical encounters using a structured and standardized data collection method
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with moderate-to-severe CHE by a dermatologist or other qualified healthcare provider at the time of enrollment and initiating an eligible medication.
Is at least 18 years of age or older and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted at the time of enrollment
Is willing and able to consent to participation in the registry
Is willing and able to complete registry-related forms electronically via personal devices.
Disqualifiers
None
Trial population
Subjects enrolled in this registry will be treated according to routine clinical care; treatments are prescribed at the provider's discretion and the decision to treat the subject with a drug is made prior to and independently of study participation. The clinician will determine subject visit schedules according to routine practice, patient needs, and local standard of care (SoC)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Observational (Non-Interventional) Registry
Other interventionThis is an observational (non-interventional) registry
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
CHE Disease Epidemiology and presentation
The major clinical outcome include an assessment of the epidemiology of CHE Disease; to better understand the presentation and natural history.
Time frame
Every 6 months for 10 years2
CHE Disease management, and outcomes
The major clinical outcome include an assessment of the epidemiology of CHE Disease; to better understand the management and outcomes.
Time frame
Every 6 months for 10 years Source ClinicalTrials.gov